opioids In a meta-analysis, researchers evaluated whether a lidocaine patch is beneficial for postoperative pain as an option for multimodal analgesia. The use of lidocaine patches for postoperative ...

The pharmacokinetics, safety, and tolerability of four topical lidocaine patches 5% continuously applied for 72 hours and changed every 12 or 24 hours were examined. In this randomized, prospective, ...

Amneal has received Food and Drug Administration approval for its lidocaine patch 5%. The product is a generic of Lidoderm Patch 5%. “We are pleased to announce the approval for the Lidocaine Patch, 5 ...

The U.S. lidocaine patches market is rising due to growing demand for non-opioid solutions for pain management, a rise in the prevalence rate of chronic pain conditions, and an advancement in product ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from ...

A preclinical study commissioned by Alliqua, Inc. (OTCQB: ALQA) ("Alliqua" or "the Company") concluded that the Company's investigational lidocaine transdermal patch compares favorably to the Lidoderm ...

Scilex Holding Company announced the publication of a study in Pain Medicine News revealing that patients treated with ZTlido® (lidocaine topical system 1.8%) showed a greater reduction in opioid use ...

CHADDS FORD, Pa., March 31, 2005 – Today at the 24th Annual Scientific Meeting of the American Pain Society, Endo Pharmaceuticals Inc. released new clinical trial data which found patients receiving ...

A woman in pain holding her neck Intravenous, patch lidocaine might be effective in treating, preventing chronic pain. As many as 116 million adults experience chronic pain each year in the United ...

NORTH LIMA, Ohio--(BUSINESS WIRE)--Zim’s® Max, a national consumer health brand, is excited to announce the release of the new Zim’s Max-Freeze Patches with lidocaine and menthol. Available in medium, ...

SAN FRANCISCO (CN) – A federal judge on Thursday finalized two class action settlements worth $270 million, ending four years of litigation over an alleged antitrust conspiracy to keep a generic form ...